Netherlands· NL-9628dc3cb716
Flecainide Alkaloid-INT 50 mg tabletten
A flecainide product containing flecaïnideacetaat, registered in Netherlands by Alkaloid - INT d.o.o.. The same ATC class is registered in 18 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Flecainide is registered in 18 of 19 countries.
Countries holding a registration under ATC C01BC04 (flecainide), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 11 of them publish a price we can compare per daily dose
Flecainide · ATC C01BC04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of flecainide costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.49 in France to $2.20 in Switzerland — a ×4.5 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Flecainide · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.20
- IT Italy$0.70
- ES Spain$0.61
- FR France$0.49
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- FLECAÏNIDEACETAAT
- Manufacturer
- Alkaloid - INT d.o.o.
- Country
- Netherlands (NL)
- ATC code
- C01BC04
- ATC class
- Flecainide
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id125437
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
342 interactions on record for flecainide.
Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flecainide · interactions on record
342 records
- 42 severe
- 164 moderate
- 15 minor
- 75 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- EliglustatA16AX10severe
46 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Flecainide in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesFlecainide AcetateANI Pharmaceuticals, Inc.
- United KingdomFlecainide 50mg tabletsKent Pharma (UK) Ltd
- CanadaAG-FLECAINIDEANGITA PHARMA INC.
- IrelandFlecainide 50mg TabletsTeva B.V.
- PolandFlecainide acetate HolstenHolsten Pharma GmbH
- FinlandTambocor3M Health Care Limited
- FranceFLECAINE 10 mg/ml, solution injectableVIATRIS MEDICAL
- BelgiumApocard Retard 100 mgViatris Healthcare
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Aristocor
- Belgium · Apocard Retard, Flecainide Retard Eg
- Bulgaria · Амаритон, Фелкарид
- Cyprus · Flecardia
- Czechia · Amarhyton, Amarhyton 100 Mg
- Germany · Flecadura, Flecainid
- Denmark · Flecainid Sandoz, Flecainid Stada
- Spain · Apocard, Flecainida Aurovitas
- Finland · Flecainide Orion, Tambocor
- France · Flecaine, Flecaine L.P.
- United Kingdom (Northern Ireland) · Flecainide Acetate Accord-Uk, Flecainide Acetate Brown & Burk Uk
- Greece · Amarhyton, Flecainide/Flexmed
- Croatia · Felkarid
- Ireland · Flecainide Teva, Tambocor
- Iceland · Flecainid Stada, Tambocor
- Italy · Almarytm, Flecainide Aurobindo
- Luxembourg · Apocard Retard, Flecainide Retard Eg
- Malta · Flecainide Acetate Aurobindo Pharma (Malta), Tambocor
- Norway · Flecainid Sandoz, Tambocor
- Poland · Flecainide Acetate Holsten
- Portugal · Amarhyton, Apocard
- Romania · Amarhyton, Tambocor
- Sweden · Tambocor, Tambocor Retard
- Slovenia · Felkarid
- Slovakia · Amarhyton 100 Mg, Amarhyton 50 Mg
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/36431b70-feaa-40ac-a646-6a7c5a25096f GET /v1/drugs/36431b70-feaa-40ac-a646-6a7c5a25096f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h125437_smpc.pdf",
"strength": null,
"atc_label": "Flecainide",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg125437",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"MAGNESIUMSTEARAAT (E 470b)",
"MAÏSZETMEEL, GEPREGELATINEERD",
"PLANTAARDIGE OLIE, GEHYDREERD"
],
"substances": [
"FLECAÏNIDEACETAAT"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h125437.pdf",
"authorised_at": "2021/06/10",
"procedure_number": "NL/H/4923/001",
"dispensing_status": "Uitsluitend recept",
"registration_number": "125437",
"additional_monitoring": "N"
}See everything about flecainide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.